Marit D Solbu Selected Research

Iohexol (Omnipaque)

1/2022	Serum matrix metalloproteinase 7 and accelerated glomerular filtration rate decline in a general non-diabetic population.
1/2019	Correlation Between Baseline GFR and Subsequent Change in GFR in Norwegian Adults Without Diabetes and in Pima Indians.
1/2018	Office and Ambulatory Heart Rate as Predictors of Age-Related Kidney Function Decline.
2/2017	Blood pressure and age-related GFR decline in the general population.
2/2016	Residual Associations of Inflammatory Markers with eGFR after Accounting for Measured GFR in a Community-Based Cohort without CKD.
1/2016	Elevated blood pressure is not associated with accelerated glomerular filtration rate decline in the general non-diabetic middle-aged population.
7/2014	Subclinical cardiovascular disease is associated with a high glomerular filtration rate in the nondiabetic general population.
11/2012	Physical exercise, fasting glucose, and renal hyperfiltration in the general population: the Renal Iohexol Clearance Survey in Tromsø 6 (RENIS-T6).
8/2011	GFR normalized to total body water allows comparisons across genders and body sizes.
5/2011	Estimated GFR associates with cardiovascular risk factors independently of measured GFR.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marit D Solbu Research Topics

Disease

14	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 12/2010
7	Albuminuria 12/2022 - 01/2013
7	Kidney Diseases (Kidney Disease) 01/2019 - 12/2010
5	Hypertension (High Blood Pressure) 01/2022 - 06/2014
4	Chronic Renal Insufficiency 01/2021 - 01/2015
3	Ischemic Stroke 11/2018 - 09/2015
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 12/2008
3	Diabetes Mellitus 01/2018 - 12/2010
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2019
2	Inflammation (Inflammations) 08/2021 - 01/2019
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 09/2015
2	Myocardial Infarction 11/2018 - 01/2018
2	Stroke (Strokes) 09/2015 - 12/2010
1	Fibrosis (Cirrhosis) 01/2022
1	Obesity 01/2022
1	Humeral Fractures 01/2021
1	Heart Failure 01/2019
1	Isolated Systolic Hypertension 02/2017
1	Hypertrophy 01/2017
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2017
1	Overweight 05/2016
1	Hyperuricemia 01/2016
1	Insulin Resistance 01/2016
1	Atrial Fibrillation 09/2015
1	Carotid Artery Diseases 01/2013
1	Hyperinsulinism (Hyperinsulinemia) 07/2011

Drug/Important Bio-Agent (IBA)

11	Iohexol (Omnipaque)FDA Link 01/2022 - 12/2010
6	CreatinineIBA 01/2022 - 12/2010
5	AlbuminsIBA 12/2022 - 12/2008
5	Uric Acid (Urate)IBA 01/2022 - 05/2016
4	Cystatin CIBA 01/2021 - 12/2010
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 07/2011
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 02/2017
2	HDL CholesterolIBA 08/2021 - 01/2018
2	AdiponectinIBA 01/2017 - 01/2016
1	Orosomucoid (Seromucoid)IBA 12/2022
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2022
1	purineIBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Biological ProductsIBA 01/2019
1	Syndecan-4IBA 11/2018
1	Syndecan-1 (Syndecan 1)IBA 11/2018
1	C-Reactive ProteinIBA 01/2018
1	LDL CholesterolIBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	Hexosaminidases (Hexosaminidase)IBA 02/2016
1	Insulin (Novolin)FDA Link 01/2016
1	Phosphates (Orthophosphate)IBA 12/2015
1	Warfarin (Coumadin)FDA LinkGeneric 09/2015
1	TEMPOIBA 01/2013

Therapy/Procedure

2	Denervation 01/2021 - 01/2016
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2019 - 09/2015
2	Renal Dialysis (Hemodialysis) 01/2018 - 09/2015